Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2017 1
2019 4
2020 6
2021 4
2022 1
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

17 results

Results by year

Filters applied: . Clear all
Page 1
Decitabine potentiates efficacy of doxorubicin in a preclinical trastuzumab-resistant HER2-positive breast cancer models.
Buocikova V, Longhin EM, Pilalis E, Mastrokalou C, Miklikova S, Cihova M, Poturnayova A, Mackova K, Babelova A, Trnkova L, El Yamani N, Zheng C, Rios-Mondragon I, Labudova M, Csaderova L, Kuracinova KM, Makovicky P, Kucerova L, Matuskova M, Cimpan MR, Dusinska M, Babal P, Chatziioannou A, Gabelova A, Rundén-Pran E, Smolkova B. Buocikova V, et al. Among authors: miklikova s. Biomed Pharmacother. 2022 Mar;147:112662. doi: 10.1016/j.biopha.2022.112662. Epub 2022 Jan 25. Biomed Pharmacother. 2022. PMID: 35091237 Free article.
Chemotherapy-triggered changes in stromal compartment drive tumor invasiveness and progression of breast cancer.
Plava J, Burikova M, Cihova M, Trnkova L, Smolkova B, Babal P, Krivosikova L, Janega P, Rojikova L, Drahosova S, Bohac M, Danisovic L, Kucerova L, Miklikova S. Plava J, et al. Among authors: miklikova s. J Exp Clin Cancer Res. 2021 Sep 27;40(1):302. doi: 10.1186/s13046-021-02087-2. J Exp Clin Cancer Res. 2021. PMID: 34579743 Free PMC article.
Increased Stromal Infiltrating Lymphocytes Are Associated with the Risk of Disease Progression in Mesenchymal Circulating Tumor Cell-Positive Primary Breast Cancer Patients.
Smolkova B, Cierna Z, Kalavska K, Miklikova S, Plava J, Minarik G, Sedlackova T, Cholujova D, Gronesova P, Cihova M, Majerova K, Karaba M, Benca J, Pindak D, Mardiak J, Mego M. Smolkova B, et al. Among authors: miklikova s. Int J Mol Sci. 2020 Dec 12;21(24):9460. doi: 10.3390/ijms21249460. Int J Mol Sci. 2020. PMID: 33322711 Free PMC article.
Epigenetics in Breast Cancer Therapy-New Strategies and Future Nanomedicine Perspectives.
Buocikova V, Rios-Mondragon I, Pilalis E, Chatziioannou A, Miklikova S, Mego M, Pajuste K, Rucins M, Yamani NE, Longhin EM, Sobolev A, Freixanet M, Puntes V, Plotniece A, Dusinska M, Cimpan MR, Gabelova A, Smolkova B. Buocikova V, et al. Among authors: miklikova s. Cancers (Basel). 2020 Dec 3;12(12):3622. doi: 10.3390/cancers12123622. Cancers (Basel). 2020. PMID: 33287297 Free PMC article. Review.
Napabucasin overcomes cisplatin resistance in ovarian germ cell tumor-derived cell line by inhibiting cancer stemness.
Schmidtova S, Dorssers LCJ, Kalavska K, Gillis AJM, Oosterhuis JW, Stoop H, Miklikova S, Kozovska Z, Burikova M, Gercakova K, Durinikova E, Chovanec M, Mego M, Kucerova L, Looijenga LHJ. Schmidtova S, et al. Among authors: miklikova s. Cancer Cell Int. 2020 Aug 3;20:364. doi: 10.1186/s12935-020-01458-7. eCollection 2020. Cancer Cell Int. 2020. PMID: 32774158 Free PMC article.
17 results